Shanghai Shen Lian Biomedical Corporation (SHA:688098)

Market Cap	3.55B +50.7%
Revenue (ttm)	288.27M -5.0%
Net Income	-19.09M
EPS	-0.05
Shares Out	410.64M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,444,047
Average Volume	2,502,986
Open	8.52
Previous Close	8.60
Day's Range	8.48 - 8.82
52-Week Range	4.97 - 17.57
Beta	0.73
RSI	45.50
Earnings Date	Apr 29, 2026

About SHA:688098

Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 374
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688098

Financial Performance

In 2025, SHA:688098's revenue was 288.27 million, a decrease of -4.99% compared to the previous year's 303.41 million. Losses were -19.09 million, -57.33% less than in 2024.